Nephros, Inc.
NEPH
$4.36
$0.307.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.72M | 19.12M | 18.79M | 17.93M | 16.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.72M | 19.12M | 18.79M | 17.93M | 16.68M |
| Cost of Revenue | 8.03M | 7.66M | 7.16M | 6.59M | 6.11M |
| Gross Profit | 12.70M | 11.46M | 11.63M | 11.34M | 10.57M |
| SG&A Expenses | 9.48M | 9.27M | 9.00M | 8.56M | 8.05M |
| Depreciation & Amortization | 124.00K | 130.00K | 140.00K | 142.00K | 142.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.08M | 18.45M | 17.64M | 16.49M | 15.35M |
| Operating Income | 1.64M | 677.00K | 1.15M | 1.45M | 1.34M |
| Income Before Tax | 1.75M | 788.00K | 1.21M | 1.51M | 1.35M |
| Income Tax Expenses | 16.00K | 12.00K | 12.00K | 27.00K | 24.00K |
| Earnings from Continuing Operations | 1.74 | 0.78 | 1.19 | 1.48 | 1.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.74M | 776.00K | 1.19M | 1.48M | 1.33M |
| EBIT | 1.64M | 677.00K | 1.15M | 1.45M | 1.34M |
| EBITDA | 1.77M | 805.00K | 1.29M | 1.59M | 1.48M |
| EPS Basic | 0.16 | 0.07 | 0.11 | 0.14 | 0.13 |
| Normalized Basic EPS | 0.10 | 0.05 | 0.07 | 0.09 | 0.08 |
| EPS Diluted | 0.16 | 0.07 | 0.11 | 0.13 | 0.12 |
| Normalized Diluted EPS | 0.10 | 0.04 | 0.07 | 0.09 | 0.08 |
| Average Basic Shares Outstanding | 42.77M | 42.51M | 42.46M | 42.36M | 42.29M |
| Average Diluted Shares Outstanding | 44.35M | 44.05M | 43.68M | 43.03M | 42.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |